Suppr超能文献

[冠状动脉内输注链激酶和维拉帕米治疗对心肌梗死患者梗死面积的影响]

[Effect of intracoronary streptokinase infusion and verapamil treatment on the size of the affected area in myocardial infarct patients].

作者信息

Vasil'tsev Ia S, Karpov R S, Markov V A, Varvarenko V I, Kun V I

出版信息

Kardiologiia. 1986 Aug;26(8):58-63.

PMID:3761850
Abstract

The effect of intracoronary streptokinase administration (31 patients), verapamil treatment (23 patients) and conventional therapy (27 patients) on the size of the affected area was examined in patients with acute myocardial infarction (MI). Streptokinase was administered in a dose of 250,000-500,000 IU within the first 3 to 20 hours of myocardial infarction, and verapamil, 360 to 400 mg, daily within the first 5 to 12 hours of the attack. The occluded coronary artery was recanalized in response to streptokinase administration in 21 patients. Serial measurements of CPK activity and serum myoglobin levels, and electrocardiographic precordial cartograms demonstrated a reduction in MI size following streptokinase administration. Verapamil had no basic effect on the final size of myocardial lesion, although it improved somewhat the clinical course of the disease.

摘要

在急性心肌梗死(MI)患者中,研究了冠状动脉内注射链激酶(31例患者)、维拉帕米治疗(23例患者)和传统治疗(27例患者)对梗死面积大小的影响。链激酶在心肌梗死的最初3至20小时内以250,000 - 500,000国际单位的剂量给药,维拉帕米在发作后的最初5至12小时内每天给药360至400毫克。21例患者在注射链激酶后闭塞的冠状动脉再通。对肌酸磷酸激酶(CPK)活性和血清肌红蛋白水平进行系列测量,以及心电图胸前导联图显示,注射链激酶后心肌梗死面积减小。维拉帕米对心肌病变的最终大小没有根本影响,尽管它在一定程度上改善了疾病的临床进程。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验